Journal List > Yeungnam Univ J Med > v.38(2) > 1160342

Kwon: Association between cystographic anastomotic urinary leakage following retropubic radical prostatectomy and early urinary incontinence



This study was performed to investigate the association between cystographic anastomotic urinary leakage (UL) after retropubic radical prostatectomy (RRP) and early urinary incontinence (UI).


The medical records of 53 patients who had undergone cystography after RRP at our institution between January 2015 and December 2018 were retrospectively analyzed. Cystography was performed 7 to 10 days after surgery. The duration of catheterization depended on the degree of UL, which was classified as mild, moderate, or severe. The study subjects were divided into the non-UL group and the UL group. Continence was defined as the use of no pads. The prostate was dissected in an antegrade fashion, and urethrovesical anastomosis was performed with a continuous suture.


Incontinence rates at 1 and 3 months postoperatively were significantly higher in the UL group than the non-UL group (83.3% vs. 52.2%, p=0.014 and 76.7% vs. 47.8%, p=0.030, respectively); however, those at 6 and 12 months were not significantly different (23.3% vs. 17.4%, p=0.597 and 4.3% vs. 10.0%, p=0.440, respectively). The severity of UL was not found to influence the duration of incontinence. The presence of cystographic anastomotic UL was found to be predictive of UI during the first 3 postoperative months (odds ratio, 3.3; p=0.045).


The presence of anastomotic UL on cystography was associated with higher rates of UI in the early postoperative periods. However, incontinence rates in patients with or without anastomotic UL immediately after RRP equalized at 6 months and the severity of UL did not affect the duration of postoperative UI.


Retropubic radical prostatectomy (RRP) is now established as the gold standard surgical management for localized prostate cancer [1,2]. However, the role of RRP has become more complex because a greater focus has been placed on patient- and cancer-specific considerations, especially those related to the balance between oncologic and functional outcomes. Unfortunately, the majority of patients who undergo RRP for prostate cancer experience treatment-related complications, especially postprostatectomy urinary incontinence (PPUI), which has a significant impact on patient quality of life [3].
RRP involves removal of the prostate and formation of a new connection between the urethra and bladder. Prostate removal is achieved by antegrade or retrograde processing, and anastomosis between the urethra and bladder is performed using a continuous or interrupted suture. In the case of open RRP, an interrupted suture is usually used, but the widespread use of laparoscopy has contributed to the proportion of procedures conducted using a continuous suture [4].
In general, cystography is performed between 1 and 2 weeks after RRP to confirm urinary leakage (UL) at the anastomosis site. One of the most common short-term complications of RRP is UL [5]. In several studies, the incidence of UL has been reported to be as high as 10% [6]. The consensus opinion is that UL does not seem to affect long-term PPUI, but early continence may be delayed due to UL, and patients with anastomotic leakage have a higher incidence of PPUI [7,8]. However, it remains unclear how the degree of UL affects urinary incontinence after RRP, and no reports on this relationship have been published in Korea.
We retrospectively analyzed the incidence and severity of UL in 53 patients who had undergone RRP at our center. These patients were divided into two groups based on the presence or absence of anastomotic UL immediately after surgery and compared with respect to possible factors responsible for UL. Moreover, the association between UL and PPUI was investigated.

Materials and methods

1. Study design and patient enrollment

After the approval of the Institutional Review Board (IRB) and Ethics Committee of Dongguk University College of Medicine (IRB No: 1107-201903-HR-03-02), 53 consecutive patients with a diagnosis of prostate cancer who had undergone RRP at our institution between January 2015 and December 2018 were enrolled in this study. Informed consent was waived by the IRB.

2. Variables inspected

Data were obtained by retrospective chart review. The variables analyzed included age, body mass index (BMI), prostate volume, operative time, estimated blood loss, duration of catheter indwelling, presence or absence of UL on postoperative cystography, and pathologic variables (i.e., preoperative prostate-specific antigen [PSA] level, postoperative Gleason score, and pathologic stage).
Cystography was performed 7 to 10 days after surgery. Normal saline (up to 200 mL) was injected to check for UL. The duration of catheterization depended on the degree of UL, which was classified as mild, moderate, or severe. UL was defined as mild when leakage was observed after injecting 200 mL, moderate if observed after injecting 100 mL, and severe if leakage occurred before injecting 100 mL normal saline (Fig. 1).
In cases of mild UL, the catheter was removed after 3 days, and for moderate UL, it was removed after 7 days [9]. In cases of severe UL, cystography was repeated at 7-day intervals with the catheter in situ until the UL ceased. The 53 study subjects were divided into two groups; the non-UL group (n=23) and the UL group (n=30).

3. Definition and assessment of continence

Continence was defined as no pad usage, as determined by patient response. Patients were asked the following question; “How many pads or adult diapers have you used daily to control leakage during the past 4 weeks?” Continence recovery was evaluated routinely at 1, 3, 6, and 12 months after RRP.

4. Surgical technique

RRP was performed in the supine position. The superficial dorsal vein was coagulated by bipolar ablation, and periprostatic fat was removed. Before disassembling the bladder and prostate, both lateral outer borders of the bladder and prostate were dissected and a cut was placed along the imaginary bladder-prostate borderline. After dissecting vas deferens and seminal vesicles, the prostate was dissected in an antegrade fashion while preserving the bilateral nerves, and hemostasis was conducted carefully. A double-stranded running suture was then placed bidirectionally from 6 o’clock to 3 and 9 o’clock and then from 3 o’clock to 9 and 12 o’clock while maintaining tension at the posterior anastomosis site to achieve anastomosis with a Monosyn 3.0 (Aesculap, Melsungen AG, Germany) suture. A catheter was then inserted, and a 120-mL saline filling test was conducted to confirm the absence of leakage.

5. Statistical analysis

The chi-square test and the Mann-Whitney test were used to analyze the demographics and perioperative outcomes. Incontinence rates at 1, 3, 6, and 12 months after surgery were analyzed using the chi-square test. Logistic regression analysis was used to identify factors that independently affected incontinence. PASW Statistics version 18.0 (IBM Corp., Armonk, NY, USA) was used for the analysis. For all comparisons, p-values of <0.05 were considered statistically significant.


Fifty-three patients who had undergone RRP were included in the study. The mean patient age was 68.8 years (range, 67–70 years), mean BMI was 24.5±2.9 kg/m2, and mean prostate size was 40.1±18.6 mL. Six patients (11.3%) had a preoperative PSA >20 ng/mL, and pathological organ-confined disease was observed in 31 patients (58.5%).
UL was detected during postoperative cystography inspections in 30 patients (56.6%); six had mild, 12 had moderate, and 12 had severe leakage. The longest period of catheterization was 38 days, which was observed in three patients. These three patients were evaluated for incontinence 1 month after removal of the Foley catheter. The mean catheterization periods for mild, moderate, and severe UL were 13.0, 17.0, and 20.1 days, respectively.
Times to catheter removal were significantly different between UL and non-UL groups (9.7±0.9 vs. 20.6±7.5, p=0.001) (Table 1). However, other perioperative characteristics and outcomes were similar. Furthermore, no significant intergroup difference was observed for pathologic data, including pathologic stage, mean Gleason score, and positive surgical margin (Table 1).
Incontinence rates at 1 and 3 months postoperatively were significantly different between UL and non-UL groups (83.3% vs. 52.2%, p=0.014 and 76.7% vs. 47.8%, p=0.030, respectively), but no significant difference was observed at 6 months (Table 2). The degree of UL was not found to influence the duration of incontinence (Table 2). In patients with severe UL, the incontinence rate at 12 months was 16.7%.
By logistic regression analysis, anastomotic UL was found to be the only significant predictor of urinary incontinence (odds ratio, 3.3; 95% confidence interval, 0.973–11.207; p=0.045) (Table 3). There were no significant factor of PPUI at 6 and 12 months (Tables 4, 5).


PPUI is a major complication of RRP and has a substantial impact on patient’s quality of life because it affects physical activity and social well-being. The reported incidence of PPUI varies from 4% to 69% [9,10], depending on multiple factors such as age, preoperative voiding status, sphincteric functional competence, perioperative bladder function, and operative factors [10-13].
The pathophysiology of PPUI is not fully understood, although several studies have suggested that intrinsic bladder sphincter deficiency, underactivity, neural injury [14,15], defects in urethral support [16], shortening of membranous urethral length, and venous sealing effects underlie the condition [17,18]. Research efforts have resulted in several surgical advances, especially the nerve-saving technique, which was recently evaluated in a large European patient cohort [19].
Although UL does not seem to affect long-term incontinence, it has been associated with early PPUI [7,8]. Consistently, in this study, the incontinence rates were significantly higher in the UL group compared to the non-UL group during the first 3 postoperative months; however, no significant intergroup difference was observed at 6 months postoperatively. Furthermore, anastomotic UL was identified as a significant prognostic factor of urinary incontinence in the early postoperative period following RRP. These findings indicate that given the absence of UL through a defective anastomotic site, adequate urinary drainage after RRP is essential to promote healing of the vesicourethral anastomosis.
In the current study, the proportion of cases with UL after RRP (56.6%) was higher than has been previously reported [20,21]. At our center, in cases of UL post-RRP, the Foley catheter is removed at 1 to 2 weeks postoperatively, depending on the degree of UL. Thus, sphincter function at the anastomosis site is likely to be abnormal during the early period. All of our patients received continuous anastomosis, and thus, approximation was more precise than that achieved using interrupted sutures. Leakage is more likely in incompletely sutured regions when interrupted sutures are used but may also occur due to loosening of the approximation with continuous anastomosis. If the Foley catheter indwelling period is sufficient, contracture is less likely during healing, and the healing period is reduced. However, when continuous suturing is performed using an open approach, the distance between 5 and 7 o’clock in the posterior anastomosis area tends to be greater than that in the anterior anastomosis area. This might have contributed to the higher prevalence of UL after RRP in the present study. Since RRP cases were performed by a single surgeon with less than 60 cases of experience, it was also considered a very important cause.
There were 12 patients with severe UL, and 2 (16.7%) of them experienced mild incontinence 1 year after RRP. These patients used only one pad per day and had no obstructive symptoms, such as a weak urine stream or hesitancy, which are the main symptoms of bladder neck contracture. Despite a short follow-up period, we were able to conclude that serious UL did not necessarily cause bladder neck contracture.
This study is limited by its retrospective, single-center design, and relatively small sample size. In fact, many factors affect PPUI, including the length of the preserved urethra after surgery, preservation of the bladder neck, sphincter injury, and preoperative voiding status. However, our study shows that postoperative cystographic UL does not develop into long-term incontinence and that in this era of robotic surgery, a continuous anastomosis suture procedure can be adopted during open RRP. No association has been previously reported between incontinence and urethrovesical anastomosis leakage in Korea.
Cystographically detected anastomotic UL was associated with higher rates of early urinary incontinence. However, continence rates were much improved 6 months after RRP in patients with anastomotic UL after surgery and the severity of UL did not affect the duration of postoperative UI.


Conflicts of interest

No potential conflict of interest relevant to this article was reported.


1. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Häggman M, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002; 347:781–9.
2. Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol. 1998; 160(6 Pt 2):2418–24.
3. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008; 358:1250–61.
4. Lim JH, Park CM, Kim HK, Park JY. Comparison of perioperative outcomes between running versus interrupted vesicourethral anastomosis in open radical prostatectomy: a single-surgeon experience. Korean J Urol. 2015; 56:443–8.
5. Tyritzis SI, Katafigiotis I, Constantinides CA. All you need to know about urethrovesical anastomotic urinary leakage following radical prostatectomy. J Urol. 2012; 188:369–76.
6. Mochtar CA, Kauer PC, Laguna MP, de la Rosette JJ. Urinary leakage after laparoscopic radical prostatectomy: a systematic review. J Endourol. 2007; 21:1371–9.
7. Patil N, Krane L, Javed K, Williams T, Bhandari M, Menon M. Evaluating and grading cystographic leakage: correlation with clinical outcomes in patients undergoing robotic prostatectomy. BJU Int. 2009; 103:1108–10.
8. Webb DR, Sethi K, Gee K. An analysis of the causes of bladder neck contracture after open and robot-assisted laparoscopic radical prostatectomy. BJU Int. 2009; 103:957–63.
9. Cormio L, Di Fino G, Scavone C, Maroscia D, Mancini V, Ruocco N, et al. Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes. Medicine (Baltimore). 2016; 95:e3475.
10. Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012; 62:405–17.
11. Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009; 55:1037–63.
12. Geraerts I, Van Poppel H, Devoogdt N, Van Cleynenbreugel B, Joniau S, Van Kampen M. Prospective evaluation of urinary incontinence, voiding symptoms and quality of life after open and robot-assisted radical prostatectomy. BJU Int. 2013; 112:936–43.
13. Xu T, Wang X, Xia L, Zhang X, Qin L, Zhong S, et al. Robot-assisted prostatectomy in obese patients: how influential is obesity on operative outcomes? J Endourol. 2015; 29:198–208.
14. Kretschmer A, Hübner W, Sandhu JS, Bauer RM. Evaluation and management of postprostatectomy incontinence: a systematic review of current literature. Eur Urol Focus. 2016; 2:245–59.
15. John H, Sullivan MP, Bangerter U, Hauri D, Yalla SV. Effect of radical prostatectomy on sensory threshold and pressure transmission. J Urol. 2000; 163:1761–6.
16. Burnett AL, Mostwin JL. In situ anatomical study of the male urethral sphincteric complex: relevance to continence preservation following major pelvic surgery. J Urol. 1998; 160:1301–6.
17. Wei JT, Dunn RL, Marcovich R, Montie JE, Sanda MG. Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol. 2000; 164(3 Pt 1):744–8.
18. Lucas MG, Bosch RJ, Burkhard FC, Cruz F, Madden TB, Nambiar AK, et al. EAU guidelines on surgical treatment of urinary incontinence. Eur Urol. 2012; 62:1118–29.
19. Bue P, Holmberg AR, Márquez M, Westlin JE, Nilsson S, Malmström PU. Intravesical administration of EGF- dextran conjugates in patients with superficial bladder cancer. Eur Urol. 2000; 38:584–9.
20. Varkarakis J, Wirtenberger W, Pinggera GM, Berger A, Harabayashi T, Bartsch G, et al. Evaluation of urinary extravasation and results after continence-preserving radical retropubic prostatectomy. BJU Int. 2004; 94:991–5.
21. Ramsden AR, Chodak GW. Can leakage at the vesico-urethral anastomosis be predicted after radical retropubic prostatectomy? BJU Int. 2004; 93:503–6.

Fig. 1.
Cystography findings and classification of urinary leakage (UL). (A) Mild UL (UL developed after bladder filling with 200 mL normal saline). (B) Moderate UL (UL developed after bladder filling with 100 mL normal saline). (C) Severe UL (UL developed before bladder filling with 100 mL normal saline).
Table 1.
Perioperative characteristics and outcomes between urinary leakage (UL) and non-UL group
Characteristic UL group (n=30) Non-UL group (n=23) p-value
Age (yr) 69.1±4.8 68.4±5.9 0.649
Body mass index (kg/m2) 25.1±2.9 23.6±2.6 0.059
Prostate volume (mL) 41.0±21.5 39.0±14.4 0.709
Preoperative PSA (ng/mL) 10.4±9.0 9.8±9.2 0.830
Mean operative time (min) 218.6±33.5 193.1±43.8 0.088
Estimated blood loss (mL) 284.7±129.8 268.2±143.0 0.664
Catheterization (day) 20.6±7.5 9.7±0.9 0.001
Pathologic stage 0.152
 T2 15 (50.0) 7 (30.4)
 T3 15 (50.0) 16 (69.6)
Pathologic Gleason score 0.615
 6 0 2 (8.7)
 7 14 (46.7) 12 (52.2)
 8 7 (23.3) 2 (8.7)
 9 9 (30.0) 6 (26.1)
 10 0 1 (4.3)
Positive surgical margin 8 (26.7) 8 (34.8) 0.524

Values are presented as mean±standard deviation or number (%).

PSA, prostate-specific antigen.

Table 2.
Incontinence rates between urinary leakage (UL) and non-UL group from 1 to 12 months and comparison of incontinence rates based on the degree of leakage
Variable Incontinence rate
1 Mo 3 Mo 6 Mo 12 Mo
 Non-UL group (n=23) 12 (52.2) 11 (47.8) 4 (17.4) 1 (4.3)
 UL group (n=30) 25 (83.3) 23 (76.7) 7 (23.3) 3 (10.0)
p-value 0.014 0.030 0.597 0.440
Degree of leakagea)
 Mild (n=6) 4 (66.7) 4 (66.7) 3 (50.0) 0
 Moderate (n=12) 11 (91.7) 10 (83.3) 1 (8.3) 1 (8.3)
 Severe (n=12) 10 (83.3) 9 (75.0) 3 (25.0) 2 (16.7)
p-valueb) 0.066 0.157 0.209 0.519

Values are presented as number (%).

a) Mild, leakage occurred after injecting 200 mL normal saline (NS); moderate, leakage occurred after injecting 100 mL NS; severe, leakage occurred before injecting 100 mL NS.

b) Non-UL group, Mild, Moderate and Severe UL group were analyzed by chi-square test.

Table 3.
Multivariate logistic regression analysis for factors of postprostatectomy urinary incontinence at 3 months
Variable OR (95% CI) p-value
Age 1.044 (0.925–1.179) 0.483
Body mass index 1.250 (0.955–1.637) 0.105
Prostate-specific antigen 1.019 (0.939–1.105) 0.655
Pathologic T stage 1.204 (0.293–4.945) 0.796
Gleason score 1.160 (0.585–2.298) 0.671
Prostate size 1.006 (0.970–1.043) 0.754
Duration of catheterization 1.317 (0.733–2.366) 0.357
Degree of leakage 1.213 (0.105–8.551) 0.111
Urinary leakage 3.301 (0.973–11.207) 0.045

OR, odds ratio; CI, confidence interval.

Table 4.
Multivariate logistic regression analysis for factors of PPUI at 6 months
Variable OR 95% CI p-value
Age 1.080 0.908–1.284 0.386
Body mass index 1.098 0.843–1.431 0.486
PSA 0.965 0.868–1.072 0.506
Pathologic T stage 5.730 0.753–43.626 0.092
Gleason score 0.409 0.133–1.252 0.117
Prostate size 1.018 0.981–1.056 0.344
Duration of catheterization 1.211 0.937–1.565 0.143
Degree of leakage 0.082 0.003–2.577 0.155
Urinary leakage 0.107 0.008–1.425 0.091

PPUI, postprostatectomy urinary incontinence; OR, odds ratio; CI, confidence interval; PSA, prostate specific antigen.

Table 5.
Multivariate logistic regression analysis for factors of PPUI at 12 months
Variable OR 95% CI p-value
Age 1.015 0.702–1.466 0.939
Body mass index 2.111 0.832–5.359 0.116
PSA 1.101 0.877–1.381 0.407
Pathologic T stage 2.985 0.094–94.440 0.535
Gleason score 2.743 0.267–28.200 0.396
Prostate size 0.862 0.636–1.168 0.339
Duration of catheterization 0.696 0.293–1.652 0.412
Degree of leakage 570.906 0.003–7.853 0.178
Urinary leakage 600.972 0.042–2.647 0.177

PPUI, postprostatectomy urinary incontinence; OR, odds ratio; CI, confidence interval; PSA, prostate specific antigen.

Similar articles